SCHEMBL23125626

SCHEMBL23125626

O=S1(=O)c2ccccc2N(c2ccccc2)c2ccc(C3(c4ccccc4)c4cccnc4-c4ncccc43)cc21

nearest known ligand 0.33

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ THPO P40225 1/20 0.31
▸ EGLN1 Q9GZT9 1/20 0.31
▸ MAOA P21397 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23125664 0.83 HTT (0.35) ALDH1A1HTTHSD17B10RXFP1CYP1A2
SCHEMBL23125599 0.80 HTT (0.36) ALDH1A1HTTHSD17B10RXFP1CYP1A2
SCHEMBL23125622 0.80 ALDH1A1 (0.32) ALDH1A1HTTHSD17B10CYP1A2CYP3A4
SCHEMBL23125591 0.79 RXFP1 (0.35) ALDH1A1RXFP1CYP1A2CYP3A4CYP2D6
SCHEMBL13143183 0.78 RXFP1 (0.41) ALDH1A1RXFP1CYP1A2CYP3A4CYP2D6
SCHEMBL18384970 0.78 ALDH1A1 (0.34) ALDH1A1HTTHSD17B10CYP1A2CYP3A4
SCHEMBL23125624 0.78 — —
SCHEMBL23125592 0.77 EGLN1 (0.32) EGLN1
SCHEMBL23125598 0.76 MEN1 (0.35) ALDH1A1RXFP1MEN1KMT2ASMN1; SMN2
SCHEMBL23125638 0.75 PGR (0.33) ALDH1A1RXFP1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10954254-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2021-03-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10954254-B2 Heterocyclic compound and organic light-emitting device including the same TYR, DDT, LEF1 ALDH1A1 60/4885HTT 2207/4885HSD17B10 1612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback